InvestorsHub Logo
icon url

Rdunn88

09/09/21 7:31 AM

#373670 RE: Here Today #373668

Exactly why this stock won't rally either way good/bad results. They will need a phase 3 and who pays and when will it complete?
icon url

loanranger

09/09/21 8:33 AM

#373691 RE: Here Today #373668

"HGEN just was told No-Go on their EUA."
HGEN said this in its release:
"the U.S. FDA has declined its request for emergency use authorization of lenzilumab to treat newly hospitalized COVID-19 patients. In its letter, FDA stated that it was unable to conclude that the known and potential benefits of lenzilumab outweigh the known and potential risks of its use as a treatment for COVID-19."
"We believe the ongoing ACTIV-5/BET-B trial*, which has been advanced to enroll up to 500 patients, may provide additional safety and efficacy data sufficient to support our efforts to obtain an EUA to treat hospitalized COVID-19 patients."


Their trial (520 participants, completed in March) is worth a look for general comparison of inclusions, exclusions, outcome measures.
https://clinicaltrials.gov/ct2/show/record/NCT04351152?term=humanigen&draw=2&rank=1


*https://clinicaltrials.gov/ct2/show/NCT04583969?term=ACTIV-5%2FBET-B&draw=2&rank=1